SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Johannsson G) "

Sökning: WFRF:(Johannsson G)

  • Resultat 1-10 av 90
  • [1]234567...9Nästa
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  • Osorio, A., et al. (författare)
  • Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2 (CIMBA)
  • 2009
  • Ingår i: British Journal of Cancer. - : Nature Publishing Group. - 0007-0920 .- 1532-1827. ; 101:12, s. 2048-2054
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: In this study we aimed to evaluate the role of a SNP in intron 1 of the ERCC4 gene (rs744154), previously reported to be associated with a reduced risk of breast cancer in the general population, as a breast cancer risk modifier in BRCA1 and BRCA2 mutation carriers. Methods: We have genotyped rs744154 in 9408 BRCA1 and 5632 BRCA2 mutation carriers from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) and assessed its association with breast cancer risk using a retrospective weighted cohort approach. Results: We found no evidence of association with breast cancer risk for BRCA1 (per-allele HR: 0.98, 95% CI: 0.93-1.04, P0.5) or BRCA2 (per-allele HR: 0.97, 95% CI: 0.89-1.06, P0.5) mutation carriers. Conclusion: This SNP is not a significant modifier of breast cancer risk for mutation carriers, though weak associations cannot be ruled out.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  • Osorio, A., et al. (författare)
  • Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
  • 2011
  • Ingår i: British Journal of Cancer. - : Nature Publishing Group. - 1532-1827 .- 0007-0920. ; 104:8, s. 1356-1361
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Single-nucleotide polymorphisms (SNPs) in genes involved in DNA repair are good candidates to be tested as phenotypic modifiers for carriers of mutations in the high-risk susceptibility genes BRCA1 and BRCA2. The base excision repair (BER) pathway could be particularly interesting given the relation of synthetic lethality that exists between one of the components of the pathway, PARP1, and both BRCA1 and BRCA2. In this study, we have evaluated the XRCC1 gene that participates in the BER pathway, as phenotypic modifier of BRCA1 and BRCA2. METHODS: Three common SNPs in the gene, c.-77C>T (rs3213245) p.Arg280His (rs25489) and p.Gln399Arg (rs25487) were analysed in a series of 701 BRCA1 and 576 BRCA2 mutation carriers. RESULTS: An association was observed between p.Arg280His-rs25489 and breast cancer risk for BRCA2 mutation carriers, with rare homozygotes at increased risk relative to common homozygotes (hazard ratio: 22.3, 95% confidence interval: 14.3-34, P<0.001). This association was further tested in a second series of 4480 BRCA1 and 3016 BRCA2 mutation carriers from the Consortium of Investigators of Modifiers of BRCA1 and BRCA2. CONCLUSIONS AND INTERPRETATION: No evidence of association was found when the larger series was analysed which lead us to conclude that none of the three SNPs are significant modifiers of breast cancer risk for mutation carriers. British Journal of Cancer (2011) 104, 1356-1361. doi:10.1038/bjc.2011.91 www.bjcancer.com Published online 22 March 2011 (C) 2011 Cancer Research UK
  •  
8.
  •  
9.
  •  
10.
  • Jakubowska, A, et al. (författare)
  • Association of PHB 1630 C andgt; T and MTHFR 677 C andgt; T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study
  • 2012
  • Ingår i: British Journal of Cancer. - : Cancer Research UK / Nature Publishing Group. - 0007-0920 .- 1532-1827. ; 106:12, s. 2016-2024
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: The variable penetrance of breast cancer in BRCA1/2 mutation carriers suggests that other genetic or environmental factors modify breast cancer risk. Two genes of special interest are prohibitin (PHB) and methylene-tetrahydrofolate reductase (MTHFR), both of which are important either directly or indirectly in maintaining genomic integrity. less thanbrgreater than less thanbrgreater thanMETHODS: To evaluate the potential role of genetic variants within PHB and MTHFR in breast and ovarian cancer risk, 4102 BRCA1 and 2093 BRCA2 mutation carriers, and 6211 BRCA1 and 2902 BRCA2 carriers from the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA) were genotyped for the PHB 1630 Candgt;T (rs6917) polymorphism and the MTHFR 677 Candgt;T (rs1801133) polymorphism, respectively. less thanbrgreater than less thanbrgreater thanRESULTS: There was no evidence of association between the PHB 1630 Candgt;T and MTHFR 677 Candgt;T polymorphisms with either disease for BRCA1 or BRCA2 mutation carriers when breast and ovarian cancer associations were evaluated separately. Analysis that evaluated associations for breast and ovarian cancer simultaneously showed some evidence that BRCA1 mutation carriers who had the rare homozygote genotype (TT) of the PHB 1630 Candgt;T polymorphism were at increased risk of both breast and ovarian cancer (HR 1.50, 95% CI 1.10-2.04 and HR 2.16, 95% CI 1.24-3.76, respectively). However, there was no evidence of association under a multiplicative model for the effect of each minor allele. less thanbrgreater than less thanbrgreater thanCONCLUSION: The PHB 1630TT genotype may modify breast and ovarian cancer risks in BRCA1 mutation carriers. This association need to be evaluated in larger series of BRCA1 mutation carriers.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 90
  • [1]234567...9Nästa
Typ av publikation
tidskriftsartikel (84)
konferensbidrag (4)
bokkapitel (1)
annan publikation (1)
Typ av innehåll
refereegranskat (85)
övrigt vetenskapligt (5)
Författare/redaktör
Johannsson, Gudmundu ... (37)
Nilsson, Anna G, 196 ... (17)
Lubinski, J (13)
Johannsson, G (13)
Johannsson, O (13)
Davidson, R. (11)
visa fler...
Radice, P (11)
Evans, DG (11)
Cook, J. (10)
Nevanlinna, H (10)
Ragnarsson, Oskar, 1 ... (10)
Liljegren, A (10)
Teixeira, MR (10)
Rennert, G. (10)
Izatt, L. (10)
Friedman, E. (9)
Benitez, J. (9)
Peterlongo, P (9)
Teo, SH (9)
Hamann, U (9)
Manoukian, S (9)
Chenevix-Trench, G (9)
McGuffog, L. (9)
Simard, J (8)
Eccles, D (8)
Buys, SS (8)
Borg, Åke (8)
Cybulski, C (8)
Eeles, RA (8)
Thomassen, M. (8)
Osorio, A. (8)
Walker, L. (8)
Stoppa-Lyonnet, D. (8)
Olsson, Håkan (7)
Glendon, G (7)
Falconer, A (7)
Gronberg, H (7)
Kote-Jarai, Z (7)
Nicolai, N (7)
Bidlingmaier, M. (7)
Olsson, Daniel S, 19 ... (7)
Olah, E (7)
Lalloo, F (7)
Frost, D. (7)
Bonanni, B. (7)
Eeles, R. (7)
Lilja, H. (7)
Maehle, L (7)
Barwell, J (7)
Suri, M (7)
visa färre...
Lärosäte
Göteborgs universitet (44)
Karolinska Institutet (29)
Lunds universitet (19)
Uppsala universitet (5)
Chalmers tekniska högskola (5)
Umeå universitet (3)
visa fler...
Linköpings universitet (3)
Kungliga Tekniska Högskolan (1)
Stockholms universitet (1)
Örebro universitet (1)
Jönköping University (1)
visa färre...
Språk
Engelska (89)
Svenska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (48)
Naturvetenskap (4)
Teknik (2)
Lantbruksvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy